Cardiva Medical Revenue and Competitors

Location

$181.2M

Total Funding

Estimated Revenue & Valuation

  • Cardiva Medical's estimated annual revenue is currently $78.4M per year.(i)
  • Cardiva Medical received $11.0M in venture funding in February 2018.
  • Cardiva Medical's estimated revenue per employee is $313,750
  • Cardiva Medical's total funding is $181.2M.

Employee Data

  • Cardiva Medical has 250 Employees.(i)
  • Cardiva Medical grew their employee count by 5% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$19.1M666%N/AN/A
#2
$8M288%N/AN/A
#3
$5M15-6%N/AN/A
#4
$8.5M26-7%N/AN/A
#5
$5.3M170%N/AN/A
#6
$49.7M1779%N/AN/A
#7
$12M48N/AN/AN/A
#8
$8.5M336%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$56.8M1499%$199.1MN/A
Add Company

Cardiva Medical is a rapidly growing medical device company that designs and develops vascular access management products that facilitate rapid hemostasis following diagnostic and interventional cardiovascular procedures. Our latest advancement is the VASCADE® Vascular Closure System. VASCADE is SAFE. SIMPLE. GUARANTEED. In the Level 1 prospective, multi-center, randomized clinical trial called RESPECT (Hermiller et al), VASCADE was proven safer than manual compression and demonstrated ZERO(0) major complications. VASCADE is elegantly SIMPLE and provides both mechanical as well as physiologic hemostasis with ~13X expansion of collagen when hydrated, utilizing extravascular bioabsorbable collagen VASCADE is GUARANTEED. Because Cardiva Medical® is so committed and confident in VASCADE®'s ability to safely and rapidly achieve hemostasis, we offer a unique value-based purchasing program called the VASCADE® Performance Guarantee. In the event of a complication as the result of VASCADE, Cardiva Medical will provide significant financial reimbursement to your hospital or practice. It's simple, were dedicated to exceptional outcomes for you and your patients. We stand behind our product based upon published clinical studies and demonstrated superior performance in the surgical theater.

keywords:Healthcare,Human Resources Hr,Medical Devices,Medical Diagnostics,Pharmaceuticals

$181.2M

Total Funding

250

Number of Employees

$78.4M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cardiva Medical's People

NameTitleEmail/Phone
1
Clinical SpecialistReveal Email/Phone
2
Regional Sales Director, NE RegionReveal Email/Phone
3
Area VPReveal Email/Phone
4
Regional Sales DirectorReveal Email/Phone
5
Territory ManagerReveal Email/Phone
6
Market Development ManagerReveal Email/Phone
7
Western Area VPReveal Email/Phone
8
Principle Clinical SpecialistReveal Email/Phone
9
Territory ManagerReveal Email/Phone
10
Territory ManagerReveal Email/Phone

Cardiva Medical News

2022-04-17 - Arterial Incision Closure Device Market 2022: Covid-19 Impact ...

... Competitive Landscape, Growth Factors, Top Venders and Forecast Till 2028 : Abbott, Cardinal Health, Arstasis, Cardiva Medical.

2022-04-17 - Global Vascular Closure Systems Market 2022 Detail Analysis ...

Cardiva Medical; Endocor. Based on product type, the market is divided into types: Vascular Closure Devices; Sealant and Suture; Others. Based...

2022-04-17 - Vascular Closure Devices Market Size And Forecast | Abbott ...

... Closure Systems Vivasure Medical Ltd., Vasorum Ltd., Morris Innovative Inc., Cardiva Medical Terumo Corporation, Essential Medical, Inc.

2020-07-14 - Cardiva Medical Announces $45 Million Financing Led by EW Healthcare Partners

Jul 14 2020 Robert S. White Joins Board of Directors SANTA CLARA, California (GLOBE NEWSWIRE)—Cardiva Medical, Inc, an innovator in the field of vascular closure, today announced the completion of a $45 million equity financing round. The equity round included new investor EW Healthcare Partne ...

2020-07-14 - Cardiva Medical Announces $45 Million Financing Led by EW Healthcare Partners

SANTA CLARA, Calif., July 14, 2020 (GLOBE NEWSWIRE) -- Cardiva Medical, Inc, an innovator in the field of vascular closure, today announced the completion of a $45 million equity financing round. The equity round included new investor EW Healthcare Partners in addition to Cardiva Medical’s exist ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$47.4M255-18%N/A
#2
$115.5M257-17%N/A
#3
$42.1M2574%N/A
#4
$41.5M2594%N/A
#5
$60.8M26049%N/A

Cardiva Medical Funding

DateAmountRoundLead InvestorsReference
2005-06-24$8.3MBStockton Partners IncArticle
2006-05-24$14.0MCGalen PartnersArticle
2008-05-07$15.5MDPTV SciencesArticle
2014-08-13$12.5MUndisclosedGE CapitalArticle
2017-03-15$30.0MUndisclosedLuther King Capital ManagementArticle
2018-02-21$11.0MUndisclosedArticle

Cardiva Medical Executives


NameTitle
John RussellPresident/CEO
Lisa GarrettCFO and VP HR
Joel GutierrezSupervisor de producción
John RussellPresident/CEO
Patrick CoulterArea Vice President
Lisa GarrettCFO and VP HR
Chad TroupArea Vice President
Paul McLeanVP Strategy
Karen DavidsonWestern Area Vice President
Roger OwensVice President Commercial Sales Marketing and Operations